| Name | Title | Contact Details |
|---|
CryoLife`s mission is to partner with clinicians to restore health by delivering innovative technologies. CryoLife is one of the world`s leading medical device companies, providing preserved human tissues for cardiac and vascular surgeries, mechanical heart valves for aortic or mitral valve replacement, surgical adhesives and sealants, vascular grafts, and state-of-the-art technology and surgical training in adult and pediatric cardiovascular surgery. CryoLife is a pioneer and leader in processing, preserving and distributing human tissues, for use in cardiac and vascular surgeries. Founded in 1984, CryoLife was the first biomedical company to specialize in low temperature preservation of human heart valves used for complex cardiac reconstruction, primarily in children born with heart defects. Since the company`s inception, it is estimated that Cryolife has received tissues from over 145,000 donors and CryoLife products and tissues have been implanted in over 1 million patients worldwide. CryoLife is headquartered in Kennesaw, Georgia, with offices in Austin, Texas, Guildford, Surrey, UK, and Hechingen, Germany, as well as sales and marketing centers in Singapore, and representation in over 85 countries worldwide. The firm`s 1000+ employees hail from 11 countries and speak 17 languages. CryoLife`s staff includes numerous full-time physicians and Ph.D.s, with disciplines in chemical engineering, biomedical engineering, biochemistry, protein chemistry and organic chemistry. CryoLife is a public company and is traded on the New York Stock Exchange under the symbol CRY.
Connect America is a Broomall, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
"ThermoTek has been the leader in thermal management technologies for more than 10 years. Our innovative ""building blocks"" for thermal management solutions include patented power supplies and temperature controllers, thermoelectric coolers,"
The Miromatrix Medical technology has the potential to enable the creation of fully biological replacement organs for the human body. In addition to the Company’s internal efforts focused on the development of its first product – a biological mesh for hernia repair – scientists around the globe are working with the Company’s technology and are taking critical steps toward the creation of human organs including the liver, lung, kidney, pancreas and heart. While our biological mesh development program has been conducted internally, our intent is for current and future products to be developed both at Miromatrix and in partnership with the best among those external groups already working with our technology in order to utilize this pre-existing expertise to develop individual products in the most efficacious, cost-effective and timely way possible.
Emmer Development Corp. is a Gainesville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.